| INSULET CORP. DL -,001 |
| USA |
| Gesundheit |
| US45784P1012 / A0MQX8 |
| GOV (Frankfurt) / PODD (NASDAQ) |
| FRA:GOV, ETR:GOV, GOV:GR, NASDAQ:PODD |
| - |
| https://www.insulet.com/ |
|
Insulet Corporation is a medical device company focused on insulin delivery and diabetes management. Its flagship Omnipod platform includes wearable, tubeless insulin management systems designed to deliver continuous insulin without traditional pump ..
>Volltext.. |
| 9480.82 Mio. EUR |
| 9841.23 Mio. EUR |
| 2717.39 Mio. EUR |
| 569.2 Mio. EUR |
| 333.99 Mio. EUR |
| 4.77 EUR |
| 844.01 Mio. EUR |
| 476.02 Mio. EUR |
| 455.02 Mio. EUR |
| 0.72 |
| 33.48% |
| 63.96% |
| - |
| - |
| - |
| - |
| INSULET |
| 04.11.26 |
|